Microdosing refers to administering doses smaller than those approved by the US Food and Drug Administration (FDA) for type 2 diabetes (T2D), weight loss, or weight loss maintenance
GLP-1 Medicare Drug Negotiation Price List In January 2025, the Centers for Medicare and Medicaid Services (CMS) announced the inclusion of GLP-1 receptor agonists specifically semaglutide-based medications Ozempic, Wegovy and Rybelsus in the second cycle of the Medicare Drug Price Negotiation Program, as per the Inflation Reduction Act
No patch can offer this level of personalized medicine because patches have not undergone the research needed to understand genetic response patterns
Stacking aggressive calorie restriction on top risks severe muscle loss and rebound when you eventually taper
PlexusDx patients report similar weight loss results (15-22% over 6+ months) at a fraction of the cost, with flexible dosing designed specifically for weight loss goals
If possible, carry your pens in an insulated container with ice gel packs